Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Haydar Bulut

9PUBLICATIONS

75CO-AUTHORS

Biomolecular modelling and designBiologically active moleculesMedical infection agents (incl. prions)Cheminformatics and quantitative structure-activity relationshipsGenetic immunology

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (9)

Sort by Publication Date:

|Feb 02, 2026

Impact of Single Halogen Atom Substitutions on Antiviral Profile of Inhibitors Targeting SARS-CoV‑2 Main Protease.

Haydar Bulut, Nobuyo Higashi-Kuwata, Hiromi Ogata-Aoki

|Jan 20, 2025

An orally available P1'-5-fluorinated M<sup>pro</sup> inhibitor blocks SARS-CoV-2 replication without booster and exhibits high genetic barrier.

Nobuyo Higashi-Kuwata, Haydar Bulut, Hironori Hayashi

|Sep 05, 2024

Structural and virologic mechanism of the emergence of resistance to M<sup>pro</sup> inhibitors in SARS-CoV-2.

Shin-Ichiro Hattori, Haydar Bulut, Hironori Hayashi

|Sep 27, 2023

Structure-Activity Relationship Studies of SARS-CoV-2 Main Protease Inhibitors Containing 4-Fluorobenzothiazole-2-carbonyl Moieties.

Kohei Tsuji, Takahiro Ishii, Takuya Kobayakawa

|Jul 12, 2023

GRL-142 binds to and impairs HIV-1 integrase nuclear localization signal and potently suppresses highly INSTI-resistant HIV-1 variants.

Manabu Aoki, Hiromi Aoki-Ogata, Haydar Bulut

|Feb 25, 2023

Identification of SARS-CoV-2 M<sup>pro</sup> inhibitors containing P1' 4-fluorobenzothiazole moiety highly active against SARS-CoV-2.

Nobuyo Higashi-Kuwata, Kohei Tsuji, Hironori Hayashi

Pageof 2

Frequent Collaborators

5 joint publications

Hirokazu Tamamura

5 joint publications

Hiroaki Mitsuya

5 joint publications

Shin-Ichiro Hattori

5 joint publications

Nobuyo Higashi-Kuwata

5 joint publications

Debananda Das

4 joint publications

Yuki Takamatsu

4 joint publications

Hironori Hayashi

4 joint publications

Naoki Kishimoto

4 joint publications

Kazuya Hasegawa

4 joint publications

Shogo Misumi

Frequent Collaborators

5 joint publications

Hirokazu Tamamura

5 joint publications

Hiroaki Mitsuya

5 joint publications

Shin-Ichiro Hattori

5 joint publications

Nobuyo Higashi-Kuwata

Top Related Videos

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on : Sep 26, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on : May 09, 2025

See more related videos

Top Related Videos

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on : Sep 26, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on : May 09, 2025

See more related videos